Taylor Tate Deborah
SEC Form 4 insider trading activity
Taylor Tate Deborah has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Jun 9, 2026.
On the most recent filing, Taylor Tate Deborah is listed as Director at HEALTHSTREAM INC. Inside the rolling window, Taylor Tate Deborah reported no open-market purchases and 1 open-market sale totaling $40K in HSTM.
Companies traded
Other insiders at HSTM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$40K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Taylor Tate Deborah made?
Taylor Tate Deborah has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Taylor Tate Deborah trade?
Taylor Tate Deborah has filed SEC Form 4 disclosures for 1 company, including HSTM.
When was Taylor Tate Deborah's most recent SEC Form 4 filing?
Taylor Tate Deborah's most recent SEC Form 4 filing on Tracefour is dated Jun 9, 2026.
What is Taylor Tate Deborah's total buy and sell value in the current window?
Inside the rolling retention window, Taylor Tate Deborah bought $0 and sold $40K based on SEC Form 4 filings.
What was Taylor Tate Deborah's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,580 HSTM shares on 2025-11-26, worth $40K, per SEC Form 4 filings.